THE COHEN DIABETIC RAT IS an experimental model of Type 2 diabetes (20) . When the animal is exposed to a customprepared diabetogenic diet (DD), diabetes develops only in the genetically susceptible (CDs), but not in the genetically resistant (CDr) strain (20) . The pathophysiology of diabetes in this model is still unresolved.
We previously initiated the investigation of the pathophysiology of diabetes in this model (21) . We reported in male rats on the presence of a highly significant quantitative trait locus (QTL) on RNO4 that was simultaneously associated with several diabetic phenotypes; we also detected two suggestive diabetes-related QTLs on RNO7 and RNOX (21) . We screened the QTL interval on RNO4 (span 4.9 cM) for known genes in the rat and in syntenic regions in the mouse and in humans and identified 23 candidate genes (21) . Our initial investigation, however, had been restricted to the male sex and overlooked the sex perspective.
The diabetic phenotype in the Cohen rodent model is different between male and female CDs: In females, the development of diabetes is slower and the metabolic phenotype is weaker than in males (20) . It is likely, therefore, that the pathophysiology of diabetes in our model is at least in part different between the sexes, as may also be the case in humans (8, 13) . This consideration led us to renew our investigation of the genetic basis of diabetes, including this time the female gender. We hypothesized that, using a genomic approach, we might detect differences between the sexes that would account for the differences in the phenotype.
METHODS

Animals.
We housed CDs and CDr rats (http://www.irgc.co.il) in our animal facility in accordance with "Principles of Laboratory Animal Care" (National Institutes of Health publication no. 85-23, revised 1985) and the guidelines of the American Physiological Society for the care of laboratory animals.The study protocol was reviewed and approved by the Institutional Committee for Animal Welfare.
Diet. We fed the animals Purina chow (Koffolk), referred to as regular diet (RD), and provided tap water ad libitum, unless stated otherwise. To elicit the diabetogenic phenotype, we provided a customprepared DD composed of 18% copper-poor casein (ICNMP Biomedicals), 72% sucrose, 4.5% butter, 0.5% corn oil, 5% salt no. II USP, distilled water, and fat-soluble vitamins that invariably causes diabetes in CDs but not in CDr, and water that was copper deficient (20) .
Overall strategy. We performed an F2 cross between CDs and CDr. We studied the male and female F2 littermates concurrently, thereby controlling for environmental/seasonal and other possible confounding factors. We used linkage and cosegregation analyses to identify within each sex diabetes-related QTLs. To provide evidence for the relevance of major QTL(s) to diabetes, we constructed consomic strain(s) and characterized their phenotype. To identify candidate genes, we searched for known genes within the QTL interval. To single out high-priority candidate genes, we studied their expression in CDs and CDr, seeking differentially expressed genes. To explain differences in gene expression, we sought sequence variations between the parental strains.
F2 cross. We cross-bred female CDr with male CDs and mated F1 brother-to-sister to generate the F2 population. We weaned F2 animals at age 1 mo and fed them with DD.
Phenotype. We derived diabetes-related phenotypes during an oral glucose tolerance test (OGTT) after 4 wk on DD (20) . We measured blood glucose levels at predetermined intervals and plasma insulin levels at 30 min (estimated glucose peak). We determined the mass of the pancreas and of other organs after sacrificing the animals at the end of the OGTT. We recorded additional phenotypes, including body weight, kidney mass, mass of epididymal fat, and plasma cholesterol and triglyceride levels.
Genotype. We scanned the genome with 121 polymorphic microsatellite markers, aiming to use markers that were spaced on each rat chromosome no more than 10 -20 cM apart. 1 When we detected a QTL, we increased the density of the markers within that chromosome. For genotype determination, we extracted genomic DNA, as previously described (22, 23) . The microsatellite primers were custom synthesized by Genosys (Sigma), using sequences provided by the Rat Genome Database (http://www.rgd.mcw.edu).
Data analyses. We analyzed the data for genetic linkage, using the MultiQTL software package version 2.5 (http://www.multiqtl.com), as previously described (24) . In brief, we initially screened the entire genome for genetic linkage, using single trait analysis (STA). We determined statistical significance (P value) of individual QTLs by permutation testing (PT) with 10,000 runs. When significance (P Ͻ 0.05) or near-significance was detected, we proceeded with bootstrap analysis (BA) 10,000 runs, which provided us with the power of QTL detection, the chromosomal position of the peak of the logarithm of the odds (LOD) score, the 95-99.9% confidence intervals of the QTL span and the percent of the phenotypic variation accounted for by the QTL. We utilized the default unrestricted model, but strove at each step of the analysis to fit the QTL to the simplest and statistically justified model (dominant, recessive, or additive effect). In parallel, we analyzed the data for cosegregation of the F2 phenotypes with the sensitivity (S) and resistance (R) alleles of CDs and CDr, respectively, using one-way ANOVA and post hoc least significance difference testing.
Generation of consomic strain. The results of our genome scan led us to identify one major QTL common to both sexes, for which we constructed a consomic strain, as previously described (22) . In brief, we cross-bred homozygous male CDs (SS) with female CDr (RR) 1 The online version of this article contains supplemental material. 0=  15=  30=  60=  120=  180=   RNO1  --------------------RNO2  --------------------RNO3 -
Results in male (M) and female (F) F2 rats shown on left and right side of each cell, respectively. AUC, area under the curve; Glc/Ins30=, ratio of glucose-to-plasma insulin at 30 min of the oral glucose tolerance test (OGTT). -, No statistical significance, *P Ͻ 0.01; †P Ͻ 0.001 by permutation testing. rats, backcrossed F1 heterozygotes (SR) to the parental female CDs (BC1), selected heterozygotes at loci of interest within the targeted chromosome, and backcrossed again to CDs for at least eight times. We then cross-bred heterozygotes and confirmed fixation of the allele of interest in resulting homozygotes on the background of the other strain by performing a total genome scan with Ͼ100 microsatellite markers. We designated the resulting consomic strain by the order of RECIPIENT.CHROMOSOME NUMBER DONOR . We characterized the phenotype of the consomic strain after feeding with DD for 4 wk.
Identification of candidate genes. We screened the 95% confidence interval of the QTL for known genes or transcripts in the rat and in syntenic regions in the mouse and in humans, using the web-based genome browser UCSC Genome Bioinformatics http://genome.ucsc.edu/cgibin/hgGateway?hgsidϭ156748931&clade ϭmammal&orgϭRat&dbϭ0, November 2004 (Baylor 3.4/rn4) assembly.
Expression analysis. We studied in the pancreas of CDs and CDr the level of expression of the genes found within the QTL at the mRNA level by semiquantitative reverse transcriptase (RT) PCR. We obtained pancreatic tissue by dissecting out the entire organ in the anesthetized animal after completing the OGTT and snap-freezing it. For RNA extraction, we homogenized the pancreas in Tri Reagent (Molecular Research Center, Cincinnati, OH), using 1 g total RNA to create the first strand with the Reverse-IT kit (ABgene) and applying the random decamer option. We amplified the first strand, using the appropriate primer and conditions, ran the PCR product on agarose gel, analyzed the UV image by densitometry, and normalized the results, using Gapdh as reference gene.
Sequencing. In preparation for sequencing of transcribed elements of our candidate genes, we extracted total RNA from the pancreas and carried out RT-PCR and PCR amplification in parts, using specifically designed primers (http://frodo.wi.mit.edu/primer3/). In view of difficulties we encountered in attempting to sequence one of the Ndufa4 exons, we used for sequencing of that one particular exon genomic DNA, as opposed cDNA for all other Ndufa4 and Ica1 exons. To sequence promoter regions, we extracted genomic DNA by salt precipitation, phenol-chloroform cleaning and amplification in parts by PCR reaction. We cleaned the PCR products by the mini prep kit and ran them on low melting point agarose gel. We sequenced the PCR products using an ABI sequencer (Weizmann Institute, Crown Human Genome Center). We used the NCBI-Blast software (http://www.ncbi.nlm. nih.gov/BLAST/) to identify sequence variations between CDs and CDr. To identify the promoter regions, we used the database http:// www.cbrc.jp/htbin/nph-tfsearch. 
F2 cross.
We initially screened the entire rat genome for genetic linkage in 132 male and 159 female F2 rats, using STA mode on a genome-wide scale (Table 1 ). In males, we detected linkage on RNO4 for glucose levels during the OGTT, insulin levels and mass of the pancreas. We found additional linkage on RNO18 for glucose levels at one time point only during the OGTT (15=); as it did not recur at any additional time point, we did not pursue it further, assuming it being a false positive. In females, we also detected linkage on RNO4 for glucose levels, insulin levels and mass of the pancreas, on RO11 for glucose levels and mass of the pancreas, on RO13 (as for RNO4) and on RNO20 only for the mass of the pancreas. We found additional linkage for glucose at single time points during the OGTT on RNO14 (time 0), 15 (15=), and 18 (60=) but did not pursue them any further, as they did not recur at additional time points.
We selected chromosomes 4, 11, 13, and 20, in which we found significant linkage during the primary screening, for additional in-depth linkage analysis, the results of which are provided below by chromosome and sex.
RNO4. In males, we pursued the analysis of the QTLs relevant to blood glucose levels during the OGTT (expressed as area under the curve, AUC), plasma insulin (expressed as the glucose-to-insulin ratio) and the mass of the pancreas. Details of the analysis are provided in Table 2 and LOD score tracings for the AUC, glucose-to-insulin ratio at 30 min and the mass of the pancreas in Fig. 1 . As the three phenotypes were interrelated and their QTL overlapped, we combined them using the multitrait analysis mode. Details of the analysis are provided in Table 2 and the LOD score tracing in Fig. 2A . We identified thereby a highly significant QTL, with a span limited to 7.8 cM (95% confidence interval). Importantly, this QTL coincided with the QTL we detected in our previous cross in males (21) . We confirmed the QTL by cosegregation analysis (Table 3) , the SS genotype being associated with higher glucose levels, a higher glucose-to-insulin ratio and a lower pancreatic mass than in SR or RR.
In females, we detected a QTL on RNO4 for the same phenotypes as in males which also overlapped with that in males. Details of the analysis are provided in Table 2 and the LOD score tracing in Fig. 1 . Multitrait analysis incorporating the three phenotypes yielded a highly significant QTL with an unprecedented low span of Ͻ0.5 cM and a peak LOD score in the vicinity of the microsatellite marker D4GOT157 (Table 2 and Fig. 2B ). We confirmed the QTL by cosegregation analysis (Table 3) , the SS genotype being associated with higher glucose levels, a higher glucose-to-insulin ratio and a lower pancreatic mass than in the SR or RR.
Since the QTL in males and females in the current cross overlapped with the QTL in the previous cross (21), we sought to identify a QTL common to both sexes in the current and previous crosses. We combined the data from the previous cross and the current cross including both sexes and analyzed the resulting composite dataset for genetic linkage. We were able to combine the data, as the study protocols in the previous and current crosses were identical. Details of the resulting analysis are provided in Table 2 and the LOD score tracing in Fig. 2C . The resulting QTL had a narrow span of only 2.6 cM.
RNO11. In males, we did not detect linkage on RNO11. In females, we detected a QTL for blood glucose levels at 30 and 60 min of the OGTT, as well as for the mass of the pancreas. Details of the analysis are provided in Table 2 and the LOD score tracings in Fig. 3, A and B . We confirmed the QTL by cosegregation analysis (Table 3) , the SS genotype being associated with higher glucose levels and lower pancreatic mass than in SR or RR. RNO13. In males, we did not detect linkage on RNO13. In females, we detected a QTL for blood glucose levels at 30, 60, and 120 min of the OGTT, AUC, glucose/insulin ratio at 30 min of the OGTT and mass of the pancreas (Table 2 and Fig.  3, C, D, and E, respectively) . We confirmed the QTL by cosegregation analysis (Table 3) , the SS genotype being associated with higher glucose and glucose-to-insulin ratio at 30 min of the OGTT, as well as lower pancreatic mass than in RR.
RNO20. We did not detect linkage on this chromosome in males. In females, we detected a QTL for the mass of the pancreas (Table 2 and Fig. 3F) . We confirmed the QTL by cosegregation analysis (Table 3) , the SS genotype, however, being associated with higher pancreatic mass than in SR or RR, suggesting a protective effect of the S allele.
Other chromosomes. We did not detect any additional diabetes related QTLs in males or females, not even on RNO7 and RNOX on which we had previously identified in males suggestive QTLs (21) .
Consomic strain. We constructed a consomic strain for RNO4 to confirm the functional significance of the diabetesrelated QTL that we had detected in the course of the study in both males and females. In the resulting CDs.4
CDr , glucose levels during the OGTT were significantly reduced compared with CDs but still remained significantly above those in CDr in both males (n ϭ 18) and females (n ϭ 4) (Fig. 4, A/C and B/D,  respectively) . The mass of the pancreas, however, was higher in the consomic strain than in the diabetic CDs animals fed DD and not different from that in CDs fed RD in both males and females (Fig. 4, E and F, respectively) . The histology of the pancreas in the consomic strain fed DD appeared normal and not different from CDr or CDs fed RD (Fig. 5) . In contrast, the pancreas in CDs fed DD looked grossly abnormal: Even though the islets of Langerhans looked normal, the acinar structures comprising the exocrine portion of the pancreas were scattered and in disarray, their rounded structure having collapsed, with remarkably fewer zymogen granules within the acinar cells (Fig. 5) .
Identification of candidate genes within the QTL on RNO4. The chromosomal segment on RNO4 (95% CI) that overlaps the QTLs for blood glucose, plasma insulin, and mass of the pancreas of the crosses in both males and females lies between positions 33,606,020 and 38,029,988 and is defined by D4Mgh26 and D4Rat15. This segment incorporates in the rat and in syntenic regions in the mouse and in humans at least six known genes: Ica1 (Islet cell autoantigen 1), Nxph1 (Neurexophilin 1), PHf14 (PHD finger protein 14), Ndufa4 [NADH dehydrogenase (ubiquinone) 1␣], Glccic (Testhymin), and Thsd7a (thrombo-spondin, type I, domain containing 7A). More genes may eventually emerge, as the list is constantly updated.
Expression of candidate genes. We studied the transcription of the six known genes at the mRNA level in parental CDs and CDr provided RD or DD. SS, homozygous for the S allele from Cohen diabetes susceptible (CDs); RR, homozygous for the R allele from Cohen diabetes resistant (CDr); SR, heterozygous. We compared between genotypes the values for the AUC, Glc/Ins at 30= of the OGTT and pancreatic mass by 1-way ANOVA with post hoc analysis by the least significant difference test.
Only Ica1 and Ndufa4 were differentially expressed between the strains, (Fig. 6, A and B, respectively) . The expression of Ica1 was lowest in CDs provided DD, whereas it was similar in CDs and CDr fed RD and not different from that in CDr provided DD. Ndufa4 mRNA levels were consistently lower in CDs compared with CDr, with no significant differences between diets within each strain. There was no difference in the level of mRNA of Nxph1, PHf14, Glccic, or Thsd7a between CDs and CDr on diabetogenic or regular diet (not shown).
In CDs.4 CDr fed DD, Ica1 mRNA expression was similar to that in CDr and higher than in CDs fed DD (Fig. 6C) . Ndufa4 mRNA levels were similar to those found in CDr and significantly higher than in CDs animals, irrespective of diet, (Fig. 6D) .
Sequencing of candidate genes. Since only Ica1 and Ndufa4 were differentially expressed between the strains, we initiated the search for sequence variations between CDs and CDr within these two genes.
Ica1. Three known isoforms have been reported: L20900 and BC078812, which include 15 (13 coding) exons, and BC063810, which includes only the first 11 exons (http:// genome.ucsc.edu/). Most of the variations between transcripts are found in the untranslated exons 1 and 2. We confirmed the presence of all three isoforms in CDs and CDr.
To identify sequence variations between CDs and CDr, we sequenced exons 1-15, using cDNA. In exon 1, we found that the sequence of the three isoforms was identical in CDs and CDr and not different from that reported in the UCSC database. In exon 2, we found that the sequence of BC078812 and L209200, which consist of 150 bases, was similar to that reported by UCSC but that BC063810 had instead of 221 bases an additional 58 bases (total 308 bases). There were no differ- Fig. 3 . LOD score tracing in females for linkage on RNO11 for blood glucose levels at 30 min (A) and for the mass of the pancreas (B), on RNO13 for the OGTT area under the curve (C), plasma glucose-to-insulin ratio at 30 min (D), and for the mass of the pancreas (E), and on RNO20 for the mass of the pancreas (F). Horizontal bar, QTL 95% confidence interval; ' , point of maximal LOD score. Linkage analysis was using the single or multitrait modality, as applicable.
ences, however, between CDs and CDr in the sequences of the three isoforms. In exons 3-15, we did not detect differences between CDs and CDr either, but we found several differences from Brown Norway, as reported by UCSC (version 3.4/rn4): In exon 4, nucleotides (tg) at position 598 -599 were replaced with (gc) and in exon 12, the nucleotide (g) at position 1473 was substituted with (t) and the nucleotide (g) at position 1485 was replaced with (a).
We sequenced the two predicted promoter regions: One for isoforms L209200 and BC068310 and a second for BC078812. In the first promoter region, the genomic DNA was identical in CDs and CDr. The promoter region for BC078812, which we sequenced up to 200 bp upstream exon 1, was similar in CDs and CDr but contrary to the sequence reported in UCSC, we found that the nucleotide (g) at position 42 upstream exon was replaced with (a).
Ndufa4. The gene sequence has not yet been reported in the rat. We used the sequence reported in humans and in the mouse (UCSC) to predict the sequence in the rat and determined it consisted of 4 exons with a transcribed region of 249 bp and translation length of 82 amino acids. We sequenced the transcribed coding regions (cDNA) and genomic DNA 150 bases upstream exon 1. We did not find sequence variations between CDs and CDr in the four exons composing the gene, nor in the promoter region. Notably, we did not identify in the predicted promoter region conventional TATA and CAAT promoter sequences but found other initiation and transcription regulation sites, including two cap signal sites for transcription initiation and regulation binding sites sequences, including STRE (stress response regulating element), ADR1 (alcohol dehydrogenase regulating gene 1), HSF (heat-shock factor), and GATA binding transcription factor. We also found that the 3=-untranslated region between the end of exon 4 and the poly A tail (110 bp) incorporates GATA binding transcription factors sites and C/EBP (CCAAT/enhancer binding protein).
QTLs for additional phenotypes. We identified QTLs that were indirectly related to diabetes, including body weight, weight of liver, epididymal fat, heart, and kidney and plasma lipid profile. The results, shown in Table 4 , are provided for reference only, and were not studied further.
DISCUSSION
Our major findings in the current genetic dissection of diabetes in the Cohen rat model relate to the one QTL that we detected on RNO4, whose functional relevance we validated in both sexes with consomic strains. We identified within the QTL two genes that were differentially expressed between CDs and CDr, allowing us to single out Ica1 and Ndufa4 as high-priority candidate genes for both sexes. These findings provided us with novel insight with regards to the pathophysiology of diabetes in our model.
We initiated in the current study a sex-specific investigation of the genetic basis of diabetes to account for differences that we had previously observed between the sexes in the diabetic phenotype of our rodent model (20) . This required us to repeat an F2 cross in males and perform a de novo cross in females. In the repeat cross in males, we reproduced our findings in the first genome scan and successfully confirmed one major QTL on RNO4 (21) . We failed, however, to reproduce two suggestive QTLs on RNO7 and X (21) . The failure of these QTLs to resurface during the repeat cross may have been because these QTLs were false positives. Alternatively, environmental factors may have been responsible for their disappearance, since the two crosses were performed at different time points. In the de novo cross in females, we detected the QTL on RNO4 that overlapped with the male locus. In addition, we detected three other diabetes-related QTLs on RNO11, 13, and 20 that did not appear in males. The findings stemming out from the new F2 crosses thus point to at least one major diabetes-related QTL that is common to both sexes, attesting to its dominant role in the development of the diabetic phenotype in our model and suggesting a mechanism that is shared by both sexes. The three additional QTLs in females may incorporate genes that are responsible for the phenotypic differences between the sexes. These sex-specific QTLs are of particular interest, as they may provide clues on how to attenuate the diabetic phenotype, which tends to be milder in females. Unfortunately, these QTLs span relatively large chromosomal segments, and extensive investigation is further required before candidate genes can be positively identified within them.
How do the diabetes-related QTLs we currently detected compare with those reported by others? Previous studies in the rat have identified no less than 110 diabetes-related QTLs (http://www.rgd.mcw.edu/) and at least five on RNO4, including Iddm2 (6), Iddm11 (1, 10), Iddm14 (11), Iddm38 (4), and Iddm39 (4). Our RNO4 QTL does not overlap with any of these other QTLs and is therefore novel. With regards to the additional sex-specific QTLs, web-based databases reveal the presence on RNO11 of Iddm17 (25) , Niddm22, and Niddm50 (18) on RNO13 of Iddm12 (10) and on RNO20 of Iddm37 (2). Iddm17, Iddm12, and Iddm20 do not coincide with our QTLs, but Iddm17 and NIddm22 overlap with our QTL on RNO11.
We pursued the detection of our major QTL on RNO4 by newly constructing a consomic strain that provided us with unequivocal functional evidence for the contribution of this QTL to glucose tolerance in both sexes. Notably, however, even though glucose levels during the OGTT were significantly reduced in the consomic strain compared with CDs, they did not fully normalize, as there was only a 30% reduction in males and 50% in females. The most likely explanation for this incomplete reduction in glucose level is that our candidate genes Ica1 and Ndufa4, whose expression in that strain was not different from those in CDr, do not account for all the impairment in glucose metabolism. Additional, yet undetected, QTLs are therefore likely to come into play in the pathogenesis of diabetes in our model, whether physiological or expression QTLs (pQTL or eQTL, respectively). We cannot rule out epigenetic effects as well. Interestingly, introgressing RNO4 from CDr onto the background of CDs had a greater effect on the mass and histology of the pancreas than on glucose metabolism, as both phenotypes were not different in the consomic strain than in CDs fed RD. These findings suggest dissociation of the pathophysiology of the impairment in glucose metabolism from the changes in mass and histology that occur in the pancreas of CDs during feeding with DD (19 -21) . We reasoned that since the RNO4 QTL recurred in two separate crosses and in both sexes, it was the major genomic locus to pursue. In our previous analysis of the first F2 cross in males, the span of the QTL had been 4.9 cM and a screen for known genes within that QTL in the rat and in syntenic regions in the mouse and humans revealed 23 candidate genes (21) . We currently successfully narrowed the span of the QTL to 2.6 cM and reduced the number of known genes in the rat to at least six. We then made the working assumption that genes that participate in the pathogenesis of disease are likely, although not necessarily, to be differentially expressed between CDs and CDr. We studied, therefore, the relative expression of the six candidate genes at the mRNA level in the parental strains in both sexes. We found that amongst the six known genes, only Ica1 and Ndufa4 were differentially expressed between CDs and CDr. The expression of Ica1 was lowest in CDs fed DD, suggesting that a component in the DD reduces the transcription of Ica1 in the genetically susceptible CDs strain only. The expression of Ndufa4 was lower in CDs than in CDr without any relation to diet, indicating a strain-related genetically determined trait.
We sought the cause/s for the reduced expression of Ica1 and Ndufa4 in CDs. As a first step in dealing with the complex issue of regulation of gene expression, we explored the possibility of strain-related sequence variations. We sequenced the Ica1 and Ndufa4 exons and their promoter regions but found no sequence variations. To complete this part of the investigation, a more extensive search for sequence variations is required in intronic regions and further upstream and downstream to the exons we sequenced. Additional gene regulatory pathways also remain to be explored, including the role of transcription factors and microRNAs. These are, however, beyond the scope of the current study. What are the putative roles of Ica1 and Ndufa4 in relation to diabetes? We previously discussed the potential role of Ica1, implicating dysfunction of the Golgi apparatus, leading to inability of the ␤-cell to secrete insulin (21) . Ica1 has been localized to the trans-Golgi and attributed a function in vesicle budding and trafficking to the cell membrane (17) . Most recently, Ica1 has also been localized to the cis-Golgi (3), suggesting that it may regulate transport of insulin from the endoplasmic reticulum to the Golgi apparatus as well. Diminished expression of Ica1 could thus lead to reduced transport of insulin from the endoplasmic reticulum to the Golgi apparatus and/or decreased vesicular trafficking of insulin from the Golgi apparatus to the cell membrane. As Ica1 is expressed in the pancreas mostly within ␤-cells (7), decreased pancreatic expression of Ica1 would be consistent with impaired insulin secretion but not production, which is consistent with what we have reported in our model (19) . Ndufa4, on the other hand, is a nuclear DNA-encoding accessory subunit of the mitochondrial inner membrane complex I respiratory chain NADH dehydrogenase (5) . The main function of this multiprotein enzyme complex is transport of electrons by oxidation of NADH followed by reduction of ubiquinone. The final subgroup of complex I is the hydrophobic protein (HP) fraction, which contains 24 nuclear encoded subunits, among them is Ndufa4 (16) . Ndufa4 is also considered to be an endogenous antioxidant that protects intracellular membranes from lipid peroxidation under oxidative stress (9) . Since intact mitochondrial function is required for normal insulin secretion (12, 15) , low expression of Ndufa4 could lead, under conditions of exceeding demand, to mitochondrial insufficiency.
Although the results presented in this study represent a major effort to identify, through genomic means, the pathophysiology of disease in male and female Cohen diabetic rats and significant progress has been achieved in the process, there are some limitations to the study that must be recognized. First, in our F2 cross, we mated female CDr with male CDs and did not investigate the reciprocal cross, which did not allow us to examine the potential role of parent of origin effects on the diabetic phenotype (14) . Second, we based our genetic mapping on a limited number of polymorphic microsatellite markers, which nonetheless achieved a remarkably high LOD score with an unusually narrow QTL span. The pending availability of rat SNPs for large-scale genome scanning and fine mapping will undoubtedly improve our mapping yield. Third, identification of candidate genes within a QTL is a complex process, and our selection of candidate genes was based on currently known genes within our QTL span; additional genes may eventually be found to reside within our QTL, as the lists of known genes, refseq genes for the rat and nonrat refseq genes that are based on a variety of large-scale genomic projects are updated daily. Fourth, our selection of causal genes was based on differential gene expression, which is only one of the available selection strategies. Genes can but do not necessarily have to be differentially expressed to be causal and gene expression is temporal and only a spatial snapshot, and the selection of a particular tissue, age, or treatment for expression studies may not capture relevant coordinates. Finally, sequence variations is only one possible explanation for differential gene expression, and the search for gene variants, which is complex, needs to be extended beyond the transcribed elements or promoter regions. Despite these limitations, the results of the current study constitute a very significant step forward in our investigation and understanding of the genetic and pathophysiological basis of diabetes in the male and female Cohen Diabetic rats.
